The combination of cobi and atezo in CRC is well tolerated at the maximum administered doses. These results show that pts with MSS CRC can respond to the combination of cobi and atezo, and provide support for continued evaluation of the combination. Clinical trial information: NCT01988896
Steph20021 wrote:Very cool. DK do you see any hope for us MSS non-mutants anywhere down the pipeline?
saffa wrote:I emailed the contact for NCT01988896 and they seem to be no longer recruiting? Hopefully there will be other trials coming up shortly...
Thank you for the opportunity to respond to your inquiry regarding clinical trial, GP28363, NCT01988896, Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors.
Unfortunately the study you are interested in is no longer recruiting. You may wish to review the following websites for additional trials: http://www.clinicaltrials.gov and http://www.centerwatch.com. These are where other pharmaceutical companies and educational facilities frequently post their studies, you may find one of interest.
I apologize for not being able to assist you directly and wish you the best of health.
Trial Information Support Line (TISL)"
khadars wrote:cobimetinib was approved by FDA last year, and atezolizumab was approved yesterday. i'm sure that if you find a way to convince your doctor to ask you to give you the drugs, it's possible.
i'm sorry that a clinical trial is not possible.
Users browsing this forum: Green Tea and 24 guests